Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 12, 2023
Distillery Therapeutics

A dual HDAC3 and HDAC8 degrader for breast cancer

BioCentury | Aug 14, 2023
Discovery & Translation

E3 ligase pathways for liver diseases, a trypanosome RPA1 inhibitor and more

New targets and compounds from BioCentury’s Distillery
BioCentury | Aug 11, 2023
Distillery Therapeutics

Inhibiting HDAC1 for pain and opioid withdrawal

BioCentury | Jul 12, 2019
Financial News

HitGen joins growing Shanghai IPO queue

BioCentury | May 17, 2019
Product Development

Pushing China to the forefront: When a first-in-China regulatory strategy makes sense

How patient prevalence and market access could encourage companies to launch their drugs first in China.
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

How HitGen is amplifying DNA-encoded library-based drug design
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cancer

Items per page:
1 - 10 of 45
Help Center
Username
Request a Demo
Request Training
Ask a Question